lowrance group banner

William Lowrance

Lowrance

William Lowrance, MD, MPH
will.lowrance@hci.utah.edu

Cancer Center Bio


William Lowrance, MD, MPH, is an assistant professor in the Division of Urology at the University of Utah School of Medicine and a Huntsman Cancer Institute (HCI) investigator. Dr. Lowrance is co-leader of the HCI Prostate Disease Oriented Team and a member of the HCI Cancer Control and Population Sciences program. He specializes in the surgical treatment of urologic malignancies. His practice at the Huntsman Cancer Institute primarily focuses on treating prostate cancer, bladder cancer, kidney cancer, testicular cancer, and penile cancer. He has extensive training and experience with open, laparoscopic, and robotic surgical techniques.

His research efforts focus on understanding and improving clinical outcomes for patients with urologic cancers. As a clinical outcomes researcher, he has conducted comparative effectiveness studies of outcomes between robotic and open radical prostatectomy. He also studies the cost and patterns of care, as well as disparities in treatment delivery of various genitourinary malignancies. He is investigating a possible link between chronic kidney disease and renal cancer. In addition to his health services research, he designs and conducts clinical trials studying novel approaches for the treatment of prostate, kidney, and bladder cancer.

Dr. Lowrance has published numerous peer-reviewed urologic articles, book chapters, and editorials. He is member of the American Urological Association’s Advanced Prostate Cancer Clinical Guidelines committee and serves on the editorial board for the medical journals, Urologists in Cancer Care and Frontiers in Genitourinary Oncology. He peer reviews medical manuscripts for over 10 different medical journals. Additionally, he has received a National Institutes of Health Challenge grant for studying the differences between open and robotic radical prostatectomy.

Dr. Lowrance completed his medical degree at the Medical University of South Carolina in Charleston, SC. Following medical school, he completed a General Surgery internship and Urology residency at Vanderbilt University Medical Center in Nashville, TN. He then completed a fellowship in urologic oncology at Memorial Sloan-Kettering Cancer Center in New York, NY. During this time, he also earned a masters degree in public health from Harvard University.